drugset / Trial / NCT01032499

Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir

NCT01032499

Phase 3 Unknown 120 enrolled Laboratorios Goulart S.A.
RandomizedParallel-groupOpen-labelTreatment

Summary

To measure the efficacy of Taro Elixir compare with Oxytetracycline in the treatment of boils or acne.

Timeline

Start
2010-05
Primary completion
2010-07
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytetracycline Small molecule
Subject Taro Elixir Unknown 15 ml Oral

Indications